Acquiring Company
JANEL CORP
Acquired Company
EnCor Biotechnology
New YorkGainesvilleProfessional ServicesTransportationE CommerceSupply Chain ManagementLogisticsManufacturingBiotechnologyHealth CareDescription
On October 20, 2026, Janel Corporation, through its subsidiary Antibodies Incorporated, acquired 100% of EnCor Biotechnology Inc. The acquisition was completed as per the terms of a Purchase Agreement. Janel Corporation paid a closing cash consideration and issued a subordinated promissory note as part of the transaction. This strategic acquisition strengthens Janel's position in the biotechnology sector.
Who to call at JANEL CORP, and when
When JANEL CORP changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day JANEL CORP raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at JANEL CORP, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment JANEL CORP makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired EnCor Biotechnology?
EnCor Biotechnology was acquired by JANEL CORP, based in New York. The deal was reported on October 22, 2026. Janel Corporation is a diversified service provider primarily engaged in logistics, transportation, and supply chain management services. JANEL CORP is publicly traded (JANL) and operates in Professional Services.
When did JANEL CORP acquire EnCor Biotechnology?
JANEL CORP's acquisition of EnCor Biotechnology was reported on October 22, 2026. On October 20, 2026, Janel Corporation, through its subsidiary Antibodies Incorporated, acquired 100% of EnCor Biotechnology Inc. The acquisition was completed as per the terms of a Purchase Agreement. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does EnCor Biotechnology do?
EnCor Biotechnology Inc. is a Florida corporation specializing in the development, manufacturing, and distribution of antibodies and reagents. Its products are utilized in research and treatment of neurological diseases and conditions. It is privately held, operating in Manufacturing, and is based in Gainesville.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.